NASDAQ:CURNeuralstem Competitors & Alternatives Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.88 -0.01 (-1.13 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$0.83Now: $0.88▼$0.9050-Day Range$0.69MA: $0.82▼$0.9652-Week Range$1.10Now: $0.88▼$13.78Volume1.55 million shsAverage Volume1.98 million shsMarket Capitalization$1.84 millionP/E RatioN/ADividend YieldN/ABeta1.81 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Competitors Neuralstem (NASDAQ:CUR) Competitors and AlternativesThe following companies in the "biological products, except diagnostic" industry are considered alternatives and competitors to Neuralstem.Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)AMGNAmgen2.3$225.67-2.1%$129.73 billion$23.36 billion17.69Analyst ReportAnalyst RevisionGILDGilead Sciences2.2$76.75-1.0%$96.62 billion$22.45 billion19.73Analyst ReportAnalyst RevisionBIIBBiogen1.7$306.72-2.3%$48.90 billion$14.38 billion9.47Heavy News ReportingSGENSeattle Genetics1.3$148.39-1.4%$26.04 billion$916.71 million-78.93MRNAModerna1.6$58.19-4.1%$22.23 billion$60.21 million-38.79Analyst ReportBNTXBioNTech0.9$49.18-1.7%$11.58 billion$121.63 million-51.77Analyst DowngradeNBIXNeurocrine Biosciences1.8$115.86-3.7%$10.83 billion$788.10 million62.97Analyst DowngradeQGENQiagen1.0$44.36-0.6%$10.04 billion$1.53 billion-277.25TECHBIO-TECHNE2.0$252.55-2.7%$9.92 billion$714.01 million53.39Analyst UpgradeInsider SellingARGXargenx1.2$225.95-2.3%$9.86 billion$78.17 million-47.77RGENRepligen1.4$120.26-1.3%$6.65 billion$270.24 million267.25ALLOAllogene Therapeutics1.3$42.63-0.9%$5.39 billionN/A-21.42Insider BuyingAnalyst RevisionADPTAdaptive Biotechnologies1.5$39.20-1.2%$5.03 billion$85.07 million-22.27Analyst ReportInsider SellingXLRNAcceleron Pharma1.5$91.54-0.6%$5.03 billion$73.99 million-35.34Analyst ReportONCESpark Therapeutics1.1$113.57-0.0%$4.37 billion$64.72 million-53.82Heavy News ReportingCBPOChina Biologic Products0.7$109.00-0.6%$4.33 billion$503.70 million27.59CRSPCrispr Therapeutics1.2$62.26-2.3%$3.96 billion$289.59 million83.01Insider SellingIOVAIovance Biotherapeutics1.7$31.41-1.8%$3.95 billionN/A-17.16Analyst DowngradeAnalyst RevisionBLUEbluebird bio1.5$70.98-5.7%$3.72 billion$44.67 million-4.74Analyst RevisionMNTAMomenta Pharmaceuticals1.2$32.21-6.6%$3.49 billion$23.87 million-11.50Analyst DowngradeHALOHalozyme Therapeutics2.2$23.26-1.5%$3.14 billion$195.99 million-42.29DNLIDenali Therapeutics1.4$25.93-4.1%$2.93 billion$26.68 million-11.79NVAXNovavax1.8$46.30-3.5%$2.56 billion$18.66 million-11.18Analyst DowngradeALECAlector1.0$29.99-1.1%$2.40 billion$21.22 million-16.57Analyst ReportFATEFate Therapeutics1.5$30.04-2.8%$2.33 billion$10.68 million-19.13RVMDBill.com1.8$32.85-0.5%$1.98 billionN/A0.00Heavy News ReportingSWTXSpringWorks Therapeutics1.5$37.58-7.0%$1.73 billionN/A-10.59ADVMAdverum Biotechnologies1.0$22.67-10.5%$1.65 billion$250,000.00-20.99SGMOSangamo Therapeutics1.6$10.97-2.4%$1.62 billion$102.43 million-13.22Analyst DowngradeTWSTTwist Bioscience1.3$36.86-0.6%$1.60 billion$54.38 million-8.34Analyst DowngradeInsider SellingADAPAdaptimmune Therapeutics0.9$11.25-1.2%$1.55 billion$1.12 million-8.59Insider SellingMESOMesoblast1.2$12.83-0.4%$1.50 billion$16.72 million-20.05Analyst DowngradeUnusual Options ActivityEDITEditas Medicine1.3$26.66-1.4%$1.48 billion$20.53 million-9.59BEAMBeam Therapeutics0.6$27.28-3.1%$1.45 billion$20,000.00-1.94BDTXI-Mab1.3$38.67-3.7%$1.44 billionN/A-2.28RGNXRegenxbio1.5$37.34-1.2%$1.37 billion$35.23 million-13.43CHRSCoherus Biosciences1.5$18.74-0.6%$1.33 billion$356.07 million9.56Analyst DowngradePRTOProteon Therapeutics0.8$54.59-6.0%$1.28 billionN/A-47.47CRTXCortexyme2.0$41.47-6.3%$1.24 billionN/A-20.63Analyst ReportAnalyst RevisionNSTGNanoString Technologies1.1$30.52-3.3%$1.17 billion$125.57 million-18.61CGENCompugen1.6$13.61-8.2%$1.17 billion$17.80 million-34.02PASGPassage Bio1.9$25.75-5.2%$1.17 billionN/A0.00TBIOTranslate Bio1.2$14.87-5.2%$983.91 million$7.80 million-8.75Analyst DowngradeInsider SellingORTXOrchard Therapeutics1.5$9.50-1.9%$923.97 million$2.51 million-4.97KRYSKrystal Biotech1.4$47.32-2.5%$835.39 millionN/A-38.16Analyst ReportHeavy News ReportingSRNESorrento Therapeutics2.0$4.12-6.3%$809.40 million$31.43 million-2.37Analyst DowngradeAVROAvrobio1.4$22.84-4.1%$777.28 millionN/A-8.37BCRXBioCryst Pharmaceuticals1.5$4.17-4.6%$769.10 million$48.83 million-4.44Analyst DowngradeREPLReplimune Group1.6$23.51-14.1%$739.88 millionN/A-15.47Earnings AnnouncementAnalyst ReportAnalyst RevisionHeavy News ReportingCLLSCellectis1.3$16.37-4.0%$739.40 million$22.99 million-10.36 This page was last updated on 6/5/2020 by MarketBeat.com Staff
